TransCure Biosciences (TCB) provides access to humanized immune system (HIS) and HIV mouse models for studying infectious and non-infectious diseases of the human immune system.
We also aim at developing a radical, definitive clinical cure against HIV/AIDS.
Our goal is to cure HIV/AIDS patients via autologous transplantation of bone marrow cells made resistant to HIV. We use our proprietary lentivector constructs for the repression of CCR5 co-receptor expression.
- Interview – 19th international AIDS conferenceRTS, the national swiss public television channel (for the french speaking part of Switzerland) interviewed Bernard Hirschel, member of our clinical advisory committee and co-founder of TransCure Bios...read more ->
- Welcome to the new websiteWelcome to our brand new website! A big thank you to all those who contributed to it’s creation. Please do not hesitate to leave comments to help us improve the quality of our website....read more ->